Epizyme Stock Price (NASDAQ:EPZM)

Add to My Stocks
$15 $0.9 (5.66%) EPZM stock closing price Jun 21, 2018 (Closing)
Prev Close* : $15.9
Market Cap:
$1.1B
Day Low: $14.95
52 Week Low: $11.15
Open: $15.95
Volume: -
Day High: $15.95
52 Week High: $21.40
Dividend:
0.00

Latest Stock Market News

Latest Articles

Epizyme News - From Partners

EPZM Stockcharts

View EPZM PE ratio, PS ratio stocks charts and compare with peers.
EPZM Chart
Note: Compare Epizyme stock price history with the index and industry peers.

Epizyme Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
110.33
PB ratio (
price to book ratio
)
5.21

Epizyme Returns

ROE
(return on equity)
-64%

Epizyme Financial Ratios

Asset Turnover
0
Receivables Turnover
111.11
Debt to Equity
0
Dividend Yield
0%

EPZM Industry Peers

Company Price Change (%)
Intellia Therapeutics (NTLA)29.511.28 (4.16%)
Alder Biopharma (ALDR)17.30.7 (3.89%)
Stemline Therapeutics (STML)17.10.6 (3.39%)
Kura Oncology (KURA)18.60.1 (0.53%)
Pfizer (PFE)36.30.16 (0.44%)
Merck (MRK)61.180.1 (0.16%)
Novartis (NVS)73.980.25 (0.34%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Chromadex (CDXC)3.610.15 (4.34%)
Nymox Pharmaceutical (NYMX)3.250.13 (4.17%)
Fortress Biotech (FBIO)3.240.12 (3.85%)
Dicerna Pharma (DRNA)13.080.48 (3.81%)
NeoGenomics (NEO)13.920.45 (3.34%)
Anika Therapeutics (ANIK)29.730.96 (3.34%)
ALBIREO PHARMA (ALBO)36.031.09 (3.12%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jun 22, 2018
CompanyPriceChange (%)
Alkermes (ALKS)43.657.71 (15.01%)
SANGAMO THERAP (SGMO)16.1251.93 (10.69%)
Agenus (AGEN)2.50.27 (9.75%)
Verastem (VSTM)7.660.78 (9.24%)
Arbutus Biopharma (ABUS)6.3750.63 (9%)
ZIOPHARM Oncology (ZIOP)3.290.31 (8.61%)
Amarin (AMRN)30.25 (7.69%)
Top losers from Medical-Biomed-Genetics industry
* As of Jun 22, 2018

Epizyme Inc Stock News - Partner Headlines

Epizyme Gets a New CEO   on Aug 10, 2015

Epizyme Financial Statements

income statement20172016201520142013
Net Sales or Revenues10M8M2.56M41.41M68.48M
Net Income-134.3M-110.21M-132.37M-55M-3.48M
Total Operating Expense146.84M119.83M135.1M96.45M71.6M
View Epizyme income statement
balance sheet20172016201520142013
Total Assets289.35M252.44M217.9M199.2M162.98M
Total Liabilities53.98M50.74M48.37M38.92M58.67M
Shareholders Equity235.37M201.7M169.53M160.28M104.31M
View Epizyme balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-1.73M8.15M12.03M-53.77M
Net Cash from (used by) Operating Activities-120.43M-96.37M-72.92M-35.36M-53.73M
Increase (Decrease) in Prop Plant And Equipment-0.98M-0.62M-0.18M-2.21M-0.63M
View Epizyme cash flow statement

Epizyme Stock Message Board

Epizyme stock lost 5.66%, and the last close price as of Jun 21, 2018 is $15 for EPZM stock. Stock price or share price can be used to find the total market value of a company. Epizyme market cap stands at $1.1B as of Jun 21, 2018. Epizyme valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Epizyme stock price and Epizyme share price mean the same thing. The volume of shares traded stood at 328,065 on the last trading day, as is evident from Epizyme stock chart, and EPZM stock quote data. Epizyme paid 0.00 stock dividends to its shareholders during last quarter. Epizyme stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.